Abstract: Methods and devices for determining a mass concentration of an airborne or respirable species in real time are provided. Methods can include drawing in a particulate species through an inlet and into a chamber of a resonator of a monitoring device and directing a laser beam into the chamber of the resonator and toward the particulate species such that the particulate species absorbs energy from the laser beam and transmits heat to the surrounding air within the chamber of the resonator. A power of the laser beam as it leaves the resonator and a sound pressure within the chamber of the resonator can be determined. Determining a mass concentration of the particulate species based on a ratio of the measured sound pressure and power of the laser beam, and whether the mass concentration of the particulate species exceeds a threshold concentration can be achieved.

Abstract: An implant includes a tether and a series of anchors. Each anchor includes (i) a tissue-engaging element, (ii) a head that is slidably coupled to the tether and that includes a lock that is biased to lock in a manner that locks the head to the tether, and (iii) a push-button operatively coupled to the lock. A delivery tool includes a flexible tube that is transluminally advanceable to the heart, and a driver. The driver is configured to, for each of the anchors sequentially, (i) advance the anchor through the flexible tube to the heart while the lock is maintained unlocked by the flexible tube constraining the push-button, (ii) anchor the anchor to tissue of the heart, and (iii) release the push-button by deploying the head out of the flexible tube, the lock responsively locking. Other embodiments are also described.

Abstract: A cooling management system for a plasma-facing assembly in a magnetic confinement plasma chamber, the cooling management system comprising: a plurality of coolant unit groups, each configured to provide cooling to a respective part of the plasma-facing assembly and being fluidly connected to a coolant source line; and a valve arrangement operable to control a flow rate of coolant from the coolant source line to each of the coolant unit groups dependent on the temperature at that coolant unit group.

Abstract: The present disclosure discloses systems and methods that can be implemented on the edge system in a vehicle for near real-time detection of collisions with multi-level confidence (i.e., low confidence, moderate confidence, high confidence), automated gathering and report generation of collision information required for post-accident analysis in a manner suitable for insurance company process workflow and storing the confidential collision details securely on the vehicle (edge) system. Confidence is determined by preconfigured adaptive thresholds measured by sensor data.

Abstract: Disclosed herein are system, method, and computer program product embodiments for providing a security model to customizable live applications in a cloud collaboration platform. The security approach may dedicate a frame to each live application, serving the frame from a different domain than a document in which the live application is embedded. This approach ensures that more stringent security requirements may be required of the live application and allows the data presented to the live application to be narrowly tailored. The security model may further leverage sandbox attributes and content-security policies to restrict the behavior of sandboxed and non-sandboxed live applications in accordance with best security practices.

Abstract: A portable oxygen concentrator designed for medical use where the sieve beds, adsorbers, are designed to be replaced by a patient. The concentrator is designed so that the beds are at least partially exposed to the outside of the system and can be easily released by a simple user-friendly mechanism. Replacement beds may be installed easily by patients, and all gas seals will function properly after installation.

Abstract: A gyroscopic module comprises at least one gyroscopic rotor rotatably mounted to a support, wherein the at least one gyroscopic rotor is driven by at least one first power source and at least one gimbal frame is coupled to the support of the at least one gyroscopic rotor. The gyroscopic module comprises at least one slew bearing coupled to the at least one gimbal frame to change an orientation of the at least one gyroscopic rotor, wherein the at least one slew bearing is driven by at least one second power source mounted to the at least one gimbal frame.

Abstract: A cathodic arc coating system includes alternating layers of at least one of titanium vanadium nitride (TiVN) and titanium silicon vanadium nitride (TiSiVN) disposed on a substrate; and alternating layers of titanium vanadium chromium nitride (TiVCrN) and titanium silicon vanadium nitride (TiSiVCrN) disposed on a substrate. A cathodic arc process includes a sub-hertz variable bias forming the alternating layers of alternating layers of at least one of titanium vanadium nitride (TiVN) and titanium silicon vanadium nitride (TiSiVN) disposed on a substrate; and alternating layers of titanium vanadium chromium nitride (TiVCrN) and titanium silicon vanadium nitride (TiSiVCrN) disposed on a substrate.

Abstract: A treatment device for treatment of overactive bladder conditions operates to suction to grasp and conform a mucosal tissue of the bladder wall to a portion of the tissue treatment device, and deliver energy to non-superficial target tissue at a substantially uniform depth from the mucosal tissue. The tissue treatment device incorporates multiple instruments for different functions needed to treat overactive bladder conditions. The tissue treatment device provides simplified interfaces and mechanisms for operating each of the multiple instruments in a controlled manner. Further, the tissue treatment device is configured to have a low and smooth profile that permits the tissue treatment device to be used without a tubular sheath.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: A gyroscopic module comprises at least one gyroscopic rotor rotatably mounted to a support, wherein the at least one gyroscopic rotor is driven by at least one first power source and at least one gimbal frame is coupled to the support of the at least one gyroscopic rotor. The gyroscopic module comprises at least one slew bearing coupled to the at least one gimbal frame to change an orientation of the at least one gyroscopic rotor, wherein the at least one slew bearing is driven by at least one second power source mounted to the at least one gimbal frame.

Abstract: A system and methods for cuing visual attention using one or more sensory cues. Sensory cues, such as visual and touch cues, are used to determine an area neglected by a user and presented on a screen display to cue the user to direct his/her attention to that neglected area. Sensory cues are independent of the program content—medical image, airplane pilot simulation, security x-ray pictures—conveyed on the screen display.

Abstract: In some embodiments, the instant invention provides a chemiluminescent system, including: an activator system, including: (a) at least one first solvent, (b) at least one peroxide, (c) at least one catalyst, (d) at least one second solvent, where the at least one second solvent is selected from the group consisting of: tert-butanol, 3-methyl-3-pentanol, 2-methyl-2-butanol, ethyl 2-hydroxyisobutyrate, methyl 2-hydroxyisobutyrate, ethylene glycol, propylene glycol, ethylene glycol monomethyl ether, ethylene glycol diethyl ether, ethylene glycol monobutyl ether, ethylene glycol dibutyl ether, propylene glycol dimethyl ether, and a combination thereof; where a combination of the at least one first solvent and the at least one second solvent is present in a sufficient amount in the chemiluminescent system so as to result in the chemiluminescent system producing a light having an illuminescence between 0.1 lx and 35,000 lx at a temperature ranging from ?110 degrees Celsius to 75 degrees Celsius.

Abstract: In some embodiments, the instant invention provides a chemiluminescent system, including: an activator system, including: (a) at least one first solvent, (b) at least one peroxide, (c) at least one catalyst, (d) at least one second solvent, where the at least one second solvent is selected from the group consisting of: tert-butanol, 3-methyl-3-pentanol, 2-methyl-2-butanol, ethyl 2-hydroxyisobutyrate, methyl 2-hydroxyisobutyrate, ethylene glycol, propylene glycol, ethylene glycol monomethyl ether, ethylene glycol diethyl ether, ethylene glycol monobutyl ether, ethylene glycol dibutyl ether, propylene glycol dimethyl ether, and a combination thereof; where a combination of the at least one first solvent and the at least one second solvent is present in a sufficient amount in the chemiluminescent system so as to result in the chemiluminescent system producing a light having an illuminescence between 0.1 1× and 35,000 1× at a temperature ranging from ?110 degrees Celsius to 75 degrees Celsius.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: The present invention relates to a sulfation method which processes a rare earth containing material. The material is roasted and exposed to a sulfur gas, then an aqueous leach to produce an insoluble metal oxide and a soluble rare earth sulfide. The insoluble and soluble material are separated utilizing a solid/liquid separator. Advantageously, the process eliminates the need for additional steps to precipitate the metal oxide in order to separate the metal from the rare earth. A system is also disclosed.